Mechanically, RALYL cooperated with FTO to demethylate and stabilize TGF-β2 transcripts, resulting in enhanced TGF-β signaling and subsequent PI3K/AKT activation, which contributes to enhanced HCC CSC stemness [168]. The gene discussed is FTO; the disease is hepatocellular carcinoma.